Fabry Disease: Focus on Cardiac Manifestations and Molecular Mechanisms

  title={Fabry Disease: Focus on Cardiac Manifestations and Molecular Mechanisms},
  author={A. Perrot and K. Osterziel and M. Beck and R. Dietz and C. Kampmann},
  • A. Perrot, K. Osterziel, +2 authors C. Kampmann
  • Published 2002
  • Medicine
  • Herz
  • Pathogenesis: Fabry disease is an inherited lysosomal storage disorder caused by deficiency of the enzyme α-galactosidase A. The enzyme deficiency results in accumulation of glycosphingolipids in the lysosomes n nearly all cell types and tissues leading to a multisystem disease. Manifestations include painful crisis, angiokeratomas, corneal dystrophy, and hypohydrosis. The severe renal, cerebrovascular, and cardiac involvement is predominantly responsible for premature mortality in Fabry… CONTINUE READING
    23 Citations
    O coração e a doença de Fabry-Anderson
    • 1
    Lysosomal storage disorders affecting the heart: a review.
    • 14
    Doença de Fabry
    • 10
    • PDF
    Long-term therapy with agalsidase alfa for Fabry disease: safety and effects on renal function in a home infusion setting.
    • 246
    • PDF
    Onset and progression of the Anderson-Fabry disease related cardiomyopathy.
    • 122
    Effectiveness of agalsidase alfa enzyme replacement in Fabry disease: cardiac outcomes after 10 years’ treatment
    • 41
    Narrative Review: Fabry Disease
    • J. Clarke
    • Medicine
    • Annals of Internal Medicine
    • 2007
    • 179
    • PDF


    Anderson–Fabry disease: Clinical manifestations of disease in female heterozygotes
    • 244
    Echocardiographic abnormalities and disease severity in Fabry's disease.
    • 101
    Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females
    • 575
    • PDF
    An atypical variant of Fabry's disease with manifestations confined to the myocardium.
    • 341
    New insights in cardiac structural changes in patients with Fabry's disease.
    • 215
    Prevalence of Anderson-Fabry Disease in Male Patients With Late Onset Hypertrophic Cardiomyopathy
    • 493
    • PDF
    Enzyme replacement therapy in Fabry disease: a randomized controlled trial.
    • 1,102
    • PDF
    Prevalence of lysosomal storage disorders.
    • 1,777
    • PDF
    Biochemical and molecular genetic basis of Fabry disease.
    • G. Pastores, Y. Lien
    • Biology, Medicine
    • Journal of the American Society of Nephrology : JASN
    • 2002
    • 53
    • PDF